Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Autolus Therapeutics (AUTL) Other Non-Current Assets (2018 - 2025)

Historic Other Non-Current Assets for Autolus Therapeutics (AUTL) over the last 8 years, with Q3 2025 value amounting to $1.0 million.

  • Autolus Therapeutics' Other Non-Current Assets fell 19.36% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year decrease of 19.36%. This contributed to the annual value of $963000.0 for FY2024, which is 203.46% down from last year.
  • Per Autolus Therapeutics' latest filing, its Other Non-Current Assets stood at $1.0 million for Q3 2025, which was down 19.36% from $5.3 million recorded in Q2 2025.
  • Over the past 5 years, Autolus Therapeutics' Other Non-Current Assets peaked at $5.3 million during Q2 2025, and registered a low of -$5000.0 during Q3 2022.
  • In the last 5 years, Autolus Therapeutics' Other Non-Current Assets had a median value of $980000.0 in 2023 and averaged $1.3 million.
  • As far as peak fluctuations go, Autolus Therapeutics' Other Non-Current Assets crashed by 10061.65% in 2022, and later surged by 1896000.0% in 2023.
  • Autolus Therapeutics' Other Non-Current Assets (Quarter) stood at $2.4 million in 2021, then decreased by 7.87% to $2.2 million in 2022, then crashed by 54.83% to $983000.0 in 2023, then decreased by 2.03% to $963000.0 in 2024, then grew by 7.06% to $1.0 million in 2025.
  • Its Other Non-Current Assets stands at $1.0 million for Q3 2025, versus $5.3 million for Q2 2025 and $993000.0 for Q1 2025.